Phase 1, Dose-Escalation Study of Oral CNF2024(BIIB021) in CLL

Clinical trial NCT00344786 · TERMINATED

Trial details

NCT number: NCT00344786
Sponsor: Biogen
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

B-Cell Chronic Lymphocytic Leukemia

Start date: 2006-02-01
Primary completion: 2008-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.